facts about glutathione and parkinson's disease Potential use of as a treatment for Depletion of dopamine in Parkinson's

Sikiric et al., "Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157

What Would Change This View A negative RCT in living skin If a properly powered randomized trial of at-home microinfusion with GHK-Cu versus matched topical control failed to show histologic or photographic differences at 12 weeks, that result would shift the position of this article from "biologically plausible recommendation" to "interesting hypothesis pending data." A safety signal in long-term at-home users If the consumer at-home microinfusion category began producing case reports of infection, scarring, or persistent dermal damage at rates higher than baseline microneedling, the depth recommendation would tighten or the route would be deprecated

Pharmacokinetics and organ distribution of intravenous and oral methylene blue

Source data Unprocessed gel

FOXO4-DRI has a strong preference for targeting high-SASP subpopulations of senescent cells, but it is unclear what causes heterogeneity in the SASP

There are no published human clinical trials of Dihexa, and therefore no human safety, toxicology, or pharmacokinetic data